The Bahrain Oncology Centre has made medical history by successfully treating a sickle cell disease patient using CRISPR-based gene-editing therapy, Casgevy. This marks the...
COEPTIS, Inc., a pioneering technology company dedicated to advancing cutting-edge technologies and artificial intelligence at the forefront of innovative biotechnology therapeutic solutions, today announced...
New York City Blood Center Enterprises today announced that their researchers have uncovered a critical mechanism that could potentially transform treatment approaches for Sickle...
AbbVie and Xilio Therapeutics, Inc., a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced a collaboration...
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced today its latest strategic collaboration with...
